These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 23898808)

  • 21. Cellular mechanisms of action and resistance of Plasmodium falciparum to artemisinin.
    Phompradit P; Chaijaroenkul W; Na-Bangchang K
    Parasitol Res; 2017 Dec; 116(12):3331-3339. PubMed ID: 29127525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
    Smithuis F; Kyaw MK; Phe O; Aye KZ; Htet L; Barends M; Lindegardh N; Singtoroj T; Ashley E; Lwin S; Stepniewska K; White NJ
    Lancet; 2006 Jun; 367(9528):2075-85. PubMed ID: 16798391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. K13 propeller domain mutations and pfmdr1 amplification in isolates of Plasmodium falciparum collected from Thai-Myanmar border area in 2006-2010.
    Phompradit P; Chaijaroenkul W; Muhamad P; Na-Bangchang K
    Folia Parasitol (Praha); 2019 May; 66():. PubMed ID: 31239407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
    Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
    Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study.
    Carrara VI; Lwin KM; Phyo AP; Ashley E; Wiladphaingern J; Sriprawat K; Rijken M; Boel M; McGready R; Proux S; Chu C; Singhasivanon P; White N; Nosten F
    PLoS Med; 2013; 10(3):e1001398. PubMed ID: 23472056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compliance with a three-day course of artesunate-mefloquine combination and baseline anti-malarial treatment in an area of Thailand with highly multidrug resistant falciparum malaria.
    Congpuong K; Bualombai P; Banmairuroi V; Na-Bangchang K
    Malar J; 2010 Feb; 9():43. PubMed ID: 20132537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gametocyte clearance in uncomplicated and severe Plasmodium falciparum malaria after artesunate-mefloquine treatment in Thailand.
    Tangpukdee N; Krudsood S; Srivilairit S; Phophak N; Chonsawat P; Yanpanich W; Kano S; Wilairatana P
    Korean J Parasitol; 2008 Jun; 46(2):65-70. PubMed ID: 18552540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular monitoring of Plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: implications for the future.
    Menard S; Morlais I; Tahar R; Sayang C; Mayengue PI; Iriart X; Benoit-Vical F; Lemen B; Magnaval JF; Awono-Ambene P; Basco LK; Berry A
    Malar J; 2012 Apr; 11():113. PubMed ID: 22498364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil.
    Aguiar AC; Pereira DB; Amaral NS; De Marco L; Krettli AU
    Malar J; 2014 Feb; 13():73. PubMed ID: 24581308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine.
    Brockman A; Price RN; van Vugt M; Heppner DG; Walsh D; Sookto P; Wimonwattrawatee T; Looareesuwan S; White NJ; Nosten F
    Trans R Soc Trop Med Hyg; 2000; 94(5):537-44. PubMed ID: 11132385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria.
    Gutman J; Green M; Durand S; Rojas OV; Ganguly B; Quezada WM; Utz GC; Slutsker L; Ruebush TK; Bacon DJ
    Malar J; 2009 Apr; 8():58. PubMed ID: 19358697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border.
    Saito M; Carrara VI; Gilder ME; Min AM; Tun NW; Pimanpanarak M; Viladpai-Nguen J; Paw MK; Haohankhunnatham W; Konghahong K; Phyo AP; Chu C; Turner C; Lee SJ; Duanguppama J; Imwong M; Bancone G; Proux S; Singhasivanon P; White NJ; Nosten F; McGready R
    BMC Med; 2021 Jun; 19(1):132. PubMed ID: 34107963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study of the in vitro sensitivity of Plasmodium falciparum to artemisinin in two border areas of Thailand.
    Woitsch B; Wernsdorfer G; Prajakwong S; Rojanawatsirivet C; Kollaritsch H; Wernsdorfer WH
    Wien Klin Wochenschr; 2004; 116 Suppl 4():35-40. PubMed ID: 15683041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination.
    Nosten F; Luxemburger C; ter Kuile FO; Woodrow C; Eh JP; Chongsuphajaisiddhi T; White NJ
    J Infect Dis; 1994 Oct; 170(4):971-7. PubMed ID: 7930743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphisms of the pfmdr1 but not the pfnhe-1 gene is associated with in vitro quinine sensitivity in Thai isolates of Plasmodium falciparum.
    Poyomtip T; Suwandittakul N; Sitthichot N; Khositnithikul R; Tan-ariya P; Mungthin M
    Malar J; 2012 Jan; 11():7. PubMed ID: 22221394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Artequick versus artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand.
    Tangpukdee N; Krudsood S; Thanachartwet V; Pengruksa C; Phophak N; Kano S; Li G; Brittenham GM; Looareesuwan S; Wilairatana P
    Southeast Asian J Trop Med Public Health; 2008 Jan; 39(1):1-8. PubMed ID: 18567436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of three anti-malarial regimens for uncomplicated Plasmodium falciparum malaria in Cambodia, 2009-2011: a randomized controlled trial and brief review.
    Lek D; Rachmat A; Harrison D; Chin G; Chaoratanakawee S; Saunders D; Menard D; Rogers WO
    Malar J; 2022 Sep; 21(1):259. PubMed ID: 36071520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular surveillance for drug-resistant Plasmodium falciparum in clinical and subclinical populations from three border regions of Burma/Myanmar: cross-sectional data and a systematic review of resistance studies.
    Brown T; Smith LS; Oo EK; Shawng K; Lee TJ; Sullivan D; Beyrer C; Richards AK
    Malar J; 2012 Sep; 11():333. PubMed ID: 22992214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study.
    Amaratunga C; Lim P; Suon S; Sreng S; Mao S; Sopha C; Sam B; Dek D; Try V; Amato R; Blessborn D; Song L; Tullo GS; Fay MP; Anderson JM; Tarning J; Fairhurst RM
    Lancet Infect Dis; 2016 Mar; 16(3):357-65. PubMed ID: 26774243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria.
    Price RN; Nosten F; Luxemburger C; Kham A; Brockman A; Chongsuphajaisiddhi T; White NJ
    Trans R Soc Trop Med Hyg; 1995; 89(5):523-7. PubMed ID: 8560531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.